Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

Authors: Richard E. Pratley, Aslam Amod, Søren T. Hoff, Takashi Kadowaki, Ildiko Lingvay, Michael A. Nauck, Karen Boje Pedersen, Trine Saugstrup, Juris J. Meier - The Lancet 2019 cited by 583